Clinical Trial Update: Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating efficacy and safety of neoadjuvant therapy in patients with resectable hepatocellular carcinoma (HCC) screened by a multimod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chen Xiaoping | Conditions: HCC | Phase 4 | Status: NOT_YET_RECRUITING